J Kolega
Overview
Explore the profile of J Kolega including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Increased Perviousness on CT for Acute Ischemic Stroke is Associated with Fibrin/Platelet-Rich Clots
Patel T, Fricano S, Waqas M, Tso M, Dmytriw A, Mokin M, et al.
AJNR Am J Neuroradiol
. 2020 Nov;
42(1):57-64.
PMID: 33243895
Background And Purpose: Clot perviousness in acute ischemic stroke is a potential CT imaging biomarker for mechanical thrombectomy efficacy. We investigated the association among perviousness, clot cellular composition, and first-pass...
2.
Meng H, Natarajan S, Gao L, Ionita C, Kolega J, Siddiqui A, et al.
AJNR Am J Neuroradiol
. 2010 Jan;
31(3):E35-6.
PMID: 20053800
No abstract available.
3.
Kolega J
Biochem Biophys Res Commun
. 2004 Jul;
320(3):1020-5.
PMID: 15240150
Blebbistatin was recently identified as a selective, cell-permeant inhibitor of myosin II. Because blebbistatin is likely to be used extensively with fluorescence imaging in studies of cytoskeletal dynamics, its compatibility...
4.
Kolega J
J Cell Biochem
. 1999 Nov;
75(4):629-39.
PMID: 10572246
Assembly and motor activity of non-muscle myosin II can be regulated by phosphorylation. Because myosin II-containing structures undergo continuous assembly, disassembly, and remodeling in living cells, especially during cell migration,...
5.
Kolega J, Kumar S
Cell Motil Cytoskeleton
. 1999 Jul;
43(3):255-68.
PMID: 10401581
During the crawling movements of non-muscle cells, myosin II-containing structures assemble and disassemble with a high degree of spatial and temporal heterogeneity. In order to understand how this is controlled,...
6.
Kolega J
J Cell Sci
. 1998 Jul;
111 ( Pt 15):2085-95.
PMID: 9664030
Different isoforms of non-muscle myosin II have different distributions in vivo, even within individual cells. In order to understand how these different distributions arise, the distribution and dynamics of non-muscle...
7.
Kolega J
J Cell Biochem
. 1998 Mar;
68(3):389-401.
PMID: 9518264
Fluorescently labeled smooth muscle myosin II is often used to study myosin II dynamics in non-muscle cells. In order to provide more specific tools for tracking non-muscle myosin II in...
8.
Kolega J
Exp Cell Res
. 1997 Feb;
231(1):66-82.
PMID: 9056413
Myosin II is required for normal amoeboid locomotion. In order to understand how myosin II elicits its effects on locomotive behavior, we have mapped myosin II-cytoskeleton interactions in locomoting endothelial...
9.
Taylor D, DeBiasio R, LaRocca G, PANE D, Post P, Kolega J, et al.
Toxicol Pathol
. 1994 Mar;
22(2):145-59.
PMID: 7973362
Major developments in machine-vision light microscopy and in reagent chemistry have led to a renaissance and revolution in the use of the light microscope in biology, biotechnology, and medicine. The...
10.
Kolega J, Taylor D
Mol Biol Cell
. 1993 Aug;
4(8):819-36.
PMID: 8241568
Assembly and motor activity of myosin II affect shape, contractility, and locomotion of nonmuscle cells. We used fluorescent analogues and imaging techniques to elucidate the state of assembly and three-dimensional...